MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate as Therapeutic Adjuvants. Integrated Health Research Journal, v. 3, n. (1-Supp), p. 05–16, 1 June2026.